Explore
Validate
LearnHPA018277
antibody from Atlas Antibodies
Targeting: ADARB1
ADAR2, ADAR2a, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, ADAR2d, ADAR2g, DRABA2, DRADA2, hRED1, RED1
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA018277 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA018277, RRID:AB_1844591
- Product name
- Anti-ADARB1
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human ADARB1, Gene description: adenosine deaminase, RNA-specific, B1, Alternative Gene Names: ADAR2, ADAR2a, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, ADAR2d, ADAR2g, DRABA2, DRADA2, hRED1, RED1, Validated applications: IHC, Uniprot ID: P78563, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Moderate intrinsic phenotypic alterations in C9orf72 ALS/FTD iPSC-microglia despite the presence of C9orf72 pathological features
ADAR1- and ADAR2-mediated regulation of maturation and targeting of miR-376b to modulate GABA neurotransmitter catabolism
Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment
Analysis of the circRNA and T-UCR populations identifies convergent pathways in mouse and human models of Rett syndrome.
The transcribed ultraconserved region uc.160+ enhances processing and A-to-I editing of the miR-376 cluster: hypermethylation improves glioma prognosis.
Adar RNA editing-dependent and -independent effects are required for brain and innate immune functions in Drosophila
Sensitive ADAR editing reporter in cancer cells enables high-throughput screening of small molecule libraries
ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD
ADAR2 regulates RNA stability by modifying access of decay-promoting RNA-binding proteins
ADAR-Related Activation of Adenosine-to-Inosine RNA Editing During Regeneration
Lorenzini I, Alsop E, Levy J, Gittings L, Lall D, Rabichow B, Moore S, Pevey R, Bustos L, Burciu C, Bhatia D, Singer M, Saul J, McQuade A, Tzioras M, Mota T, Logemann A, Rose J, Almeida S, Gao F, Marks M, Donnelly C, Hutchins E, Hung S, Ichida J, Bowser R, Spires-Jones T, Blurton-Jones M, Gendron T, Baloh R, Van Keuren-Jensen K, Sattler R
Frontiers in Cellular Neuroscience 2023;17
Frontiers in Cellular Neuroscience 2023;17
ADAR1- and ADAR2-mediated regulation of maturation and targeting of miR-376b to modulate GABA neurotransmitter catabolism
Widmark A, Sagredo E, Karlström V, Behm M, Biryukova I, Friedländer M, Daniel C, Öhman M
Journal of Biological Chemistry 2022;298(3):101682
Journal of Biological Chemistry 2022;298(3):101682
Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment
Hariharan A, Qi W, Rehrauer H, Wu L, Ronner M, Wipplinger M, Kresoja‐Rakic J, Sun S, Oton‐Gonzalez L, Sculco M, Serre‐Beinier V, Meiller C, Blanquart C, Fonteneau J, Vrugt B, Rüschoff J, Opitz I, Jean D, de Perrot M, Felley‐Bosco E
Molecular Oncology 2022;16(22):3949-3974
Molecular Oncology 2022;16(22):3949-3974
Analysis of the circRNA and T-UCR populations identifies convergent pathways in mouse and human models of Rett syndrome.
Siqueira E, Obiols-Guardia A, Jorge-Torres OC, Oliveira-Mateos C, Soler M, Ramesh-Kumar D, Setién F, van Rossum D, Pascual-Alonso A, Xiol C, Ivan C, Shimizu M, Armstrong J, Calin GA, Pasterkamp RJ, Esteller M, Guil S
Molecular therapy. Nucleic acids 2022 Mar 8;27:621-644
Molecular therapy. Nucleic acids 2022 Mar 8;27:621-644
The transcribed ultraconserved region uc.160+ enhances processing and A-to-I editing of the miR-376 cluster: hypermethylation improves glioma prognosis.
Soler M, Davalos V, Sánchez-Castillo A, Mora-Martinez C, Setién F, Siqueira E, Castro de Moura M, Esteller M, Guil S
Molecular oncology 2022 Feb;16(3):648-664
Molecular oncology 2022 Feb;16(3):648-664
Adar RNA editing-dependent and -independent effects are required for brain and innate immune functions in Drosophila
Deng P, Khan A, Jacobson D, Sambrani N, McGurk L, Li X, Jayasree A, Hejatko J, Shohat-Ophir G, O’Connell M, Li J, Keegan L
Nature Communications 2020;11(1)
Nature Communications 2020;11(1)
Sensitive ADAR editing reporter in cancer cells enables high-throughput screening of small molecule libraries
Fritzell K, Xu L, Otrocka M, Andréasson C, Öhman M
Nucleic Acids Research 2019;47(4):e22-e22
Nucleic Acids Research 2019;47(4):e22-e22
ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD
Moore S, Alsop E, Lorenzini I, Starr A, Rabichow B, Mendez E, Levy J, Burciu C, Reiman R, Chew J, Belzil V, W. Dickson D, Robertson J, Staats K, Ichida J, Petrucelli L, Van Keuren-Jensen K, Sattler R
Acta Neuropathologica 2019;138(1):49-65
Acta Neuropathologica 2019;138(1):49-65
ADAR2 regulates RNA stability by modifying access of decay-promoting RNA-binding proteins
Anantharaman A, Tripathi V, Khan A, Yoon J, Singh D, Gholamalamdari O, Guang S, Ohlson J, Wahlstedt H, Öhman M, Jantsch M, Conrad N, Ma J, Gorospe M, Prasanth S, Prasanth K
Nucleic Acids Research 2017
Nucleic Acids Research 2017
ADAR-Related Activation of Adenosine-to-Inosine RNA Editing During Regeneration
Witman N, Behm M, Öhman M, Morrison J
Stem Cells and Development 2013;22(16):2254-2267
Stem Cells and Development 2013;22(16):2254-2267
No comments: Submit comment
No validations: Submit validation data